Open navigation
Search
Offices – Austria
Explore all Offices
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
Insights – Austria
Explore all insights
Search
Expertise
Insights

CMS lawyers can provide future-facing advice for your business across a variety of specialisms and industries, worldwide.

Explore topics
Offices
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
CMS Austria
Insights
About CMS

Select your region

Deals 06 Jun 2025 · Austria

CMS advises Bruker

on acquisition of biocrates, a leader in mass spectrometry-based quantitative metabolomics

3 min read

On this page

On 3 June 2025 Bruker Corporation (NASDAQ: BRKR) announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. The acquisition further expands Bruker’s multiomics strategy with biocrates metabolomics kits and assays, and related software and research services.

biocrates is a global leader in mass spectrometry (MS)-based quantitative metabolite and lipid analysis kits, assays, software and services that make standardized metabolomics accessible to laboratories worldwide. The biocrates kits cover over 1,000+ metabolites from more than 40 metabolite classes, and the biocrates metabolomics technology platform combines innovative sample preparation, metabolite identification, and data analysis.
 
With this acquisition, Bruker expects to enhance its MS-based metabolomics solutions and to support its expansion into multiomics solutions, including instruments, reagents, software, and research services, thereby building on the prior acquisitions of proteomics kits, software and services companies PreOmics and Biognosys (in which both cases CMS has also been the legal advisor on Bruker's side).
 
A CMS team led by lead partners Dr. Alexander Rakosi (CMS Austria) and Dr. Hendrik Hirsch (CMS Germany) provided Bruker with comprehensive legal advice on the transaction. The success is proof of the smooth work across borders between CMS Germany and CMS Austria.

Commenting on the deal, Alexander Rakosi said: “This transaction highlights the strength and expertise of our international team and underscores CMS's ability to successfully support cross-border projects. The integration of biocrates into Bruker's portfolio will further strengthen the company's position as a leading provider of multiomics solutions.”


CMS Austria
Core Team
Alexander Rakosi, Partner, Corporate/M&A
Marie-Christine Lidl, Lawyer, Corporate/M&A
 
Team
Yara Al-Harbi, Associate, Corporate/M&A
Thomas Aspalter, Lawyer, Tax
Anna Hiegelsperger, Lawyer, Corporate/M&A
Mariella Kapoun-Reiter, Partner, Real Estate & Construction
Konstantin Kladivko, Associate, Real Estate & Construction
Lukas Kment, Associate, Real Estate & Construction
Hans Lederer, Partner, Intellectual Property
Andreas Lichtenberger, Lawyer, Data Protection
Clemens Macho, Associate, Corporate/M&A
Sibylle Novak, Partner, Tax
Caroline Pavitsits, Associate, Employment
Clara Puczynski, Associate, Real Estate & Construction
Alexander Sommergruber, Associate, Antitrust, Competition & Trade
Ferdinand Sima, Legal trainee, Corporate/M&A
Gabriela Staber, Partner, Intellectual Property
Marlene Wimmer-Nistelberger, Partner, Public Law
Jens Winter, Partner, Employment
Dieter Zandler, Partner, Antitrust, Competition & Trade

CMS Germany
Hendrik Hirsch, Lead Partner
Berrit Roth-Mingram, Counsel
Pia Konle, all Corporate/M&A
Thomas Hirse. IPTC
Moritz Pottek, Regulatory
Martin Friedberg,
Steffen Preis, both Tax

Back to top